NIM
GILD icon

Northeast Investment Management’s Gilead Sciences GILD Stock Holding History

Northeast Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,183
Closed -$231K – 208
2021
Q4 		$231K Sell
3,183
-101
-3% -$6.96K 0.01% 192
2021
Q3 		$229K Buy
+3,284
New +$231K 0.01% 184
2020
Q4 		– Sell
-5,113
Closed -$323K – 186
2020
Q3 		$323K Buy
5,113
+561
+12% +$38.9K 0.02% 142
2020
Q2 		$350K Buy
+4,552
New +$349K 0.03% 133
2018
Q4 		– Sell
-3,020
Closed -$233K – 167
2018
Q3 		$233K Sell
3,020
-1,423
-32% -$107K 0.02% 160
2018
Q2 		$315K Sell
4,443
-177
-4% -$12.5K 0.03% 140
2018
Q1 		$348K Sell
4,620
-400
-8% -$31.8K 0.03% 124
2017
Q4 		$360K Sell
5,020
-1,262
-20% -$95.8K 0.03% 130
2017
Q3 		$509K Sell
6,282
-10,172
-62% -$778K 0.05% 118
2017
Q2 		$1.17M Sell
16,454
-150,086
-90% -$9.99M 0.11% 89
2017
Q1 		$11.3M Sell
166,540
-68,249
-29% -$4.8M 1.06% 38
2016
Q4 		$16.8M Sell
234,789
-4,286
-2% -$319K 1.61% 22
2016
Q3 		$18.9M Sell
239,075
-3,124
-1% -$254K 1.89% 17
2016
Q2 		$20.2M Sell
242,199
-6,971
-3% -$619K 2.03% 18
2016
Q1 		$22.9M Buy
249,170
+3,283
+1% +$296K 2.35% 9
2015
Q4 		$24.9M Sell
245,887
-2,808
-1% -$292K 2.58% 6
2015
Q3 		$24.4M Sell
248,695
-1,167
-0.5% -$130K 2.64% 7
2015
Q2 		$29.3M Sell
249,862
-2,842
-1% -$311K 2.95% 5
2015
Q1 		$24.8M Buy
252,704
+672
+0.3% +$68.2K 2.43% 9
2014
Q4 		$23.8M Sell
252,032
-1,548
-0.6% -$160K 2.32% 10
2014
Q3 		$27M Buy
253,580
+1,064
+0.4% +$104K 2.71% 5
2014
Q2 		$20.9M Buy
252,516
+6,955
+3% +$541K 2.1% 16
2014
Q1 		$17.4M Buy
245,561
+8,844
+4% +$694K 1.85% 19
2013
Q4 		$17.8M Buy
236,717
+38,756
+20% +$2.7M 1.99% 15
2013
Q3 		$12.4M Buy
197,961
+74,691
+61% +$4.46M 1.51% 24
2013
Q2 		$6.32M Buy
+123,270
New +$6.43M 0.81% 44

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Northeast Investment Management's GILD Position: Q1 2022 in Review

Northeast Investment Management sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 3,183 shares — an estimated $231K sold.

Northeast Investment Management first reported a position in GILD in Q2 2013 and held it in 26 quarters. The position peaked at $29.3M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Northeast Investment Management reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Northeast Investment Management sold 3,183 Gilead Sciences shares in Q1 2022, an estimated $231K.
  • Northeast Investment Management first reported a position in Gilead Sciences in Q2 2013 and held it in 26 quarters.
  • Northeast Investment Management's Gilead Sciences position peaked at $29.3M in Q2 2015.
  • 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Northeast Investment Management's 13F filing for Q1 2022, filed 4 May 2022.